139 related articles for article (PubMed ID: 18308905)
1. Foresight in schizophrenia: a potentially unique and relevant factor to functional disability.
Eack SM; Keshavan MS
Psychiatr Serv; 2008 Mar; 59(3):256-60. PubMed ID: 18308905
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
3. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis.
Leeson VC; Barnes TR; Hutton SB; Ron MA; Joyce EM
Schizophr Res; 2009 Jan; 107(1):55-60. PubMed ID: 18793828
[TBL] [Abstract][Full Text] [Related]
4. Associating functional recovery with neurocognitive profiles identified using partially ordered classification models.
Jaeger J; Tatsuoka C; Berns S; Varadi F; Czobor P; Uzelac S
Schizophr Res; 2006 Jul; 85(1-3):40-8. PubMed ID: 16690254
[TBL] [Abstract][Full Text] [Related]
5. Neuroanatomical substrates of foresight in schizophrenia.
Eack SM; George MM; Prasad KM; Keshavan MS
Schizophr Res; 2008 Aug; 103(1-3):62-70. PubMed ID: 18603414
[TBL] [Abstract][Full Text] [Related]
6. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.
Smith MJ; Barch DM; Csernansky JG
Schizophr Res; 2009 Jan; 107(1):69-75. PubMed ID: 18786811
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.
Hill SK; Schuepbach D; Herbener ES; Keshavan MS; Sweeney JA
Schizophr Res; 2004 May; 68(1):49-63. PubMed ID: 15037339
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?
Villalta-Gil V; Vilaplana M; Ochoa S; Haro JM; Dolz M; Usall J; Cervilla J;
Schizophr Res; 2006 Oct; 87(1-3):246-53. PubMed ID: 16859898
[TBL] [Abstract][Full Text] [Related]
9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
10. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.
Keefe RS; Poe M; Walker TM; Harvey PD
J Clin Exp Neuropsychol; 2006 Feb; 28(2):260-9. PubMed ID: 16484097
[TBL] [Abstract][Full Text] [Related]
11. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?
Brüne M; Abdel-Hamid M; Lehmkämper C; Sonntag C
Schizophr Res; 2007 May; 92(1-3):151-9. PubMed ID: 17346931
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive correlates of recovery from schizophrenia.
Kopelowicz A; Liberman RP; Ventura J; Zarate R; Mintz J
Psychol Med; 2005 Aug; 35(8):1165-73. PubMed ID: 16116942
[TBL] [Abstract][Full Text] [Related]
13. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of cognition for different domains of outcome in recent-onset schizophrenia.
Holthausen EA; Wiersma D; Cahn W; Kahn RS; Dingemans PM; Schene AH; van den Bosch RJ
Psychiatry Res; 2007 Jan; 149(1-3):71-80. PubMed ID: 17141329
[TBL] [Abstract][Full Text] [Related]
15. Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.
Ventura J; Cienfuegos A; Boxer O; Bilder R
Schizophr Res; 2008 Nov; 106(1):59-69. PubMed ID: 17900866
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study.
Lee RS; Hermens DF; Naismith SL; Lagopoulos J; Jones A; Scott J; Chitty KM; White D; Robillard R; Scott EM; Hickie IB
Transl Psychiatry; 2015 Apr; 5(4):e555. PubMed ID: 25918992
[TBL] [Abstract][Full Text] [Related]
17. Course of cognitive functioning during the stabilization phase of schizophrenia.
Klingberg S; Wittorf A; Sickinger S; Buchkremer G; Wiedemann G
J Psychiatr Res; 2008 Mar; 42(4):259-67. PubMed ID: 17400252
[TBL] [Abstract][Full Text] [Related]
18. The influence of neurocognitive deficits and symptoms on disability in schizophrenia.
Ertuğrul A; Uluğ B
Acta Psychiatr Scand; 2002 Mar; 105(3):196-201. PubMed ID: 11939973
[TBL] [Abstract][Full Text] [Related]
19. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
20. 1-year follow-up study of cognitive function in first-episode non-affective psychosis.
Rodríguez-Sánchez JM; Pérez-Iglesias R; González-Blanch C; Pelayo-Terán JM; Mata I; Martínez O; Sánchez-Cubillo I; Vázquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2008 Sep; 104(1-3):165-74. PubMed ID: 18635340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
